Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001341004-12-000254
Filing Date
2012-02-14
Accepted
2012-02-14 14:08:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g.htm SC 13G 166796
2 EXHIBIT 1 - JOINT FILING AGREEMENT ex1.htm EX-99 20471
  Complete submission text file 0001341004-12-000254.txt   188945
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Subject) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-86638 | Film No.: 12607609
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 146 TRIDENT CHAMBERS ROAD TOWN D8 TORTOLA
Business Address P.O. BOX 146 TRIDENT CHAMBERS ROAD TOWN D8 TORTOLA 852 3556 0183
Key Gate Investments Ltd (Filed by) CIK: 0001518232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G